Improvement in Disease Severity and Quality of Life in Patients With Atopic Dermatitis Treated With Dupilumab for up to 18 Months: Real-World Evidence From the PROSE Registry
Authors: Jerry Bagel, Gil Yosipovitch, David M. Pariser, Robert Y. Lin, Haixin Zhang, Zafer Ozturk, Andrew Korotzer